Skip to main content
Premium Trial:

Request an Annual Quote

Hybrigenics Closes 16.8M in Series C Financing

NEW YORK, April 12 - French functional proteomics company Hybrigenics today said it has pocketed €16.8 million, or roughly $14.8 million, in a Series C round of venture capital financing.

The financing, which brings Hybrigenics' total take to €47 million, will be used to bolster its therapeutic-target validation, emphasizing infectious-diseases drug discovery. The funds will also help support Hybrigenics' internal and external growth, and to reinforce its international business presence, it said.

Life Sciences Partners, in the Netherlands and Germany, led the round.

The Scan

Science Confidence Boost

The New York Times reports that a new poll finds trust in science and scientists has increased with the COVID-19 pandemic.

Appeal and Funds

Some grant applications denied funding due to an Australian Research Council rule change have now been funded following an appeal, the Guardian reports.

Surveillance for Variants

Vox writes that the detection of the Omicron SARS-CoV-2 variant highlights the need for improved viral genomic surveillance.

Nature Papers Examine Taxonomic Gaps in Plant Sequencing, SARS-CoV-2-Human Interactome

In Nature this week: plant genome sequencing dominated by affluent countries, and more.